A review of compliance, depot intramuscular antipsychotics and the new long-acting injectable atypical antipsychotic risperidone in schizophrenia

Author： Bhanji N.H.   Chouinard G.   Margolese H.C.  

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.14, Iss.2, 2004-03, pp. : 87-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia: A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic

By Samtani Mahesh N.  

Clinical Pharmacokinetics, Vol. 48, Iss. 9, 2009-09 ,pp. : 585-600

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Long Acting Injectable Atypical Antipsychotics: A Review

By  

Current Clinical Pharmacology, Vol. 8, Iss. 3, 2013-08 ,pp. : 256-264

Bentham Science Publishers

Access to resources Recommend Favorite

Long-Acting Risperidone: A Review of Its Use in Schizophrenia

By Tracy Swainston Harrison   Goa K.L.  

CNS Drugs, Vol. 18, Iss. 2, 2004-01 ,pp. : 113-132

Adis International

Access to resources Recommend Favorite

Pharmacokinetic Profile and Clinical Efficacy of Long-Acting Risperidone: Potential Benefits of Combining an Atypical Antipsychotic and a New Delivery System

By Ereshefsky Larry  

Drugs in R&D, Vol. 6, Iss. 3, 2005-01 ,pp. : 129-137

Adis International

Access to resources Recommend Favorite

Long-Acting Injectable Risperidone for the Treatment of Schizophrenia: Clinical Perspectives

By Möller Hans-Jürgen  

Drugs, Vol. 67, Iss. 11, 2007-01 ,pp. : 1541-1566

Adis International

Access to resources Recommend Favorite